Form 4: Liquidia Corp's Chief Medical Officer Rajeev Saggar Reports Sale of Shares to Cover Taxes

Rajeev Saggar, Chief Medical Officer of Liquidia Corp, reports selling shares to cover taxes related to the settlement of restricted stock units.

Summary

• On July 12, 2024, Rajeev Saggar, the Chief Medical Officer of Liquidia Corp, sold 1,470 shares of common stock at a price of $12.53 per share.
• The sale was executed to cover taxes associated with the settlement of restricted stock units (RSUs) that were initially granted on January 11, 2023.
• Following the transaction, Saggar beneficially owns 210,202 shares, which includes unvested RSUs from grants made on July 18, 2022, January 11, 2023, and January 11, 2024, as well as shares acquired under the Employee Stock Purchase Plan.
• The transaction was conducted under a Rule 10b5-1 plan adopted on December 15, 2023.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction appears to be a routine sale of shares for tax purposes under a pre-arranged trading plan.

Industry Context

Sales of shares by company executives are a common occurrence, often related to compensation and tax obligations. These transactions are closely monitored by investors for insights into management's perspective on the company's value and future prospects.

Stakeholder Impact

• The sale of shares by a company executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant effect given the context of tax obligations and the pre-arranged trading plan.

Key Dates